As previously mentioned, the link between gut dysbiosis and altered profile of gut BA can reduce the FXR/PXR agonism, while promoting the IBD progression through altered BA signaling functions [66, 67, 72, 73]. This evidence concerns the gene NR1H4 and inflammatory bowel disease.